Oxford vaccine trial on hold because of potential safety issue
By Erika Edwards & Sara G. Miller
AstraZeneca CEO says participant had neurological symptoms, could be discharged today
By Adam Feuerstein
Inside Oxford's Vaccine Saga: From Wild Hype to Sobering Reality
By Elizabeth Ralph
WHO calls delay in AstraZeneca coronavirus vaccine trial a 'wake-up call'
By Noah Higgins-Dunn
Oxford Vaccine: AstraZeneca Pauses Trial After Unexplained Illness
By Michelle Cortez & Riley Griffin
Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant
By Elias Visontay
AstraZeneca Pauses Vaccine Trial for Safety Review
By Katie Thomas & Katherine J. Wu